Cite
HARVARD Citation
Rumman, A. et al. (2017). Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel Disease. Canadian journal of gastroenterology & hepatology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rumman, A. et al. (2017). Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel Disease. Canadian journal of gastroenterology & hepatology. p. . [Online].